Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Cash & Equivalents (2016 - 2026)

Research Frontiers' Cash & Equivalents history spans 11 years, with the latest figure at $664299.0 for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 66.69% to $664299.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $664299.0, a 66.69% decrease, with the full-year FY2025 number at $664299.0, down 66.69% from a year prior.
  • Cash & Equivalents hit $664299.0 in Q4 2025 for Research Frontiers, down from $1.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for REFR hit a ceiling of $4.8 million in Q3 2022 and a floor of $206524.0 in Q3 2021.
  • Historically, Cash & Equivalents has averaged $1.9 million across 5 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 96.2% in 2021 and later soared 2224.19% in 2022.
  • Tracing REFR's Cash & Equivalents over 5 years: stood at $269964.0 in 2021, then surged by 1467.21% to $4.2 million in 2022, then tumbled by 41.48% to $2.5 million in 2023, then decreased by 19.46% to $2.0 million in 2024, then tumbled by 66.69% to $664299.0 in 2025.
  • Business Quant data shows Cash & Equivalents for REFR at $664299.0 in Q4 2025, $1.1 million in Q3 2025, and $1.3 million in Q2 2025.